186 related articles for article (PubMed ID: 9026076)
21. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity.
Kimman TG; De Wind N; De Bruin T; de Visser Y; Voermans J
Virology; 1994 Dec; 205(2):511-8. PubMed ID: 7975253
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
[TBL] [Abstract][Full Text] [Related]
23. Reduced virulence of a pseudorabies virus isolate from wild boar origin in domestic pigs correlates with hampered visceral spread and age-dependent reduced neuroinvasive capacity.
Verpoest S; Redant V; Cay AB; Favoreel H; De Regge N
Virulence; 2018 Jan; 9(1):149-162. PubMed ID: 28873002
[TBL] [Abstract][Full Text] [Related]
24. The full-length microRNA cluster in the intron of large latency transcript is associated with the virulence of pseudorabies virus.
Wang X; Zhang MM; Yan K; Tang Q; Wu YQ; He WB; Chen HC; Liu ZF
Virology; 2018 Jul; 520():59-66. PubMed ID: 29777914
[TBL] [Abstract][Full Text] [Related]
25. Molecular biology of pseudorabies (Aujeszky's disease) virus.
Mettenleiter TC
Comp Immunol Microbiol Infect Dis; 1991; 14(2):151-63. PubMed ID: 1657509
[TBL] [Abstract][Full Text] [Related]
26. Construction of a US7/US8/UL23/US3-deleted recombinant pseudorabies virus and evaluation of its pathogenicity in dogs.
Yin H; Li Z; Zhang J; Huang J; Kang H; Tian J; Qu L
Vet Microbiol; 2020 Jan; 240():108543. PubMed ID: 31902487
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus.
Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H
Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent pathogenicity of a pseudorabies virus variant in pigs inoculated via intranasal route.
Wang Y; Xia SL; Lei JL; Cong X; Xiang GT; Luo Y; Sun Y; Qiu HJ
Vet Immunol Immunopathol; 2015 Dec; 168(3-4):147-52. PubMed ID: 26672913
[TBL] [Abstract][Full Text] [Related]
29. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
Kit S; Sheppard M; Ichimura H; Kit M
Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
[TBL] [Abstract][Full Text] [Related]
30. Replication and virulence of pseudorabies virus mutants lacking glycoprotein gX.
Thomsen DR; Marchioli CC; Yancey RJ; Post LE
J Virol; 1987 Jan; 61(1):229-32. PubMed ID: 3023702
[TBL] [Abstract][Full Text] [Related]
31. Study of the delivery of the gD gene of pseudorabies virus to one-day-old piglets by adenovirus or plasmid DNA as ways to by-pass the inhibition of immune response by colostral antibodies.
Le Potier MF; Monteil M; Houdayer C; Eloit M
Vet Microbiol; 1997 Apr; 55(1-4):75-80. PubMed ID: 9220598
[TBL] [Abstract][Full Text] [Related]
32. Pseudorabies (Aujeszky's disease) virus: state of the art. August 1993.
Mettenleiter TC
Acta Vet Hung; 1994; 42(2-3):153-77. PubMed ID: 7810409
[TBL] [Abstract][Full Text] [Related]
33. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.
Kit S; Kit M; Pirtle EC
Am J Vet Res; 1985 Jun; 46(6):1359-67. PubMed ID: 2992322
[TBL] [Abstract][Full Text] [Related]
34. An inactivated gE-deleted pseudorabies vaccine provides complete clinical protection and reduces virus shedding against challenge by a Chinese pseudorabies variant.
Wang J; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Gu Y; Liu C; Hou J
BMC Vet Res; 2016 Dec; 12(1):277. PubMed ID: 27923365
[TBL] [Abstract][Full Text] [Related]
35. Replication and virulence of early protein 0 and long latency transcript deficient mutants of the Aujeszky's disease (pseudorabies) virus.
Boldogköi Z; Braun A; Fodor I
Microbes Infect; 2000 Sep; 2(11):1321-8. PubMed ID: 11018448
[TBL] [Abstract][Full Text] [Related]
36. A mutant of pseudorabies virus with deletion of glycoprotein gIII gene prepared from a Japanese isolate: it fails to agglutinate mouse erythrocytes.
Yamada S; Imada T; Shimizu M; Miura Y
Vet Microbiol; 1995 Jul; 45(2-3):233-42. PubMed ID: 7571374
[TBL] [Abstract][Full Text] [Related]
37. A high-temperature passaging attenuated Pseudorabies vaccine protects piglets completely against emerging PRV variant.
Liang C; Tong W; Zheng H; Liu F; Wu J; Li G; Zhou EM; Tong G
Res Vet Sci; 2017 Jun; 112():109-115. PubMed ID: 28214681
[TBL] [Abstract][Full Text] [Related]
38. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
[TBL] [Abstract][Full Text] [Related]
39. Effects of replacing the promoter of the immediate early gene with the promoter of Drosophila heat-shock gene HSP70 on the growth and virulence of pseudorabies virus.
Glazenburg K; Gielkens A; Moormann R
Vet Microbiol; 1992 Nov; 33(1-4):35-43. PubMed ID: 1336246
[TBL] [Abstract][Full Text] [Related]
40. Deletion of pseudorabies virus US2 gene enhances viral titers in a porcine cerebral cortex primary culture system.
Lyu C; Wang S; Sun M; Tang Y; Peng J; Tian Z; Cai X
Virus Genes; 2018 Jun; 54(3):406-413. PubMed ID: 29541931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
